Mirena Efficiency and Tolerability During the First Year of Use
NCT00696202 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 199
Last updated 2014-12-31
Summary
In this trial the efficacy and safety of Mirena was investigated during the first year of use
Conditions
- Medicated Intrauterine Devices
- Contraception
Interventions
- DRUG
-
Mirena (BAY86-5028)
Intrauterine levonorgestrel containing device (market product)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 25 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2005-03-31
Countries
- France
Study Locations
More Related Trials
-
Scandinavian Mirena Insertion Nulliparous Trial.
NCT00798980 ·Status: COMPLETED
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development
NCT02490774 ·Status: TERMINATED ·Phase: PHASE2
-
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
NCT01833793 ·Status: COMPLETED
-
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
NCT01590537 ·Status: COMPLETED
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
MiCo - Mirena or Conventional Medical Treatment for Menorrhagia
NCT01085487 ·Status: COMPLETED
-
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
NCT00185380 ·Status: COMPLETED ·Phase: PHASE2
-
Mirena in Idiopathic Menorrhagia
NCT00868153 ·Status: COMPLETED
-
Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
NCT02475356 ·Status: COMPLETED
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
Mirena Observational Program
NCT00883662 ·Status: COMPLETED
-
Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding
NCT00874653 ·Status: COMPLETED
-
Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
NCT03657602 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years
NCT02903888 ·Status: COMPLETED
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED
-
Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial
NCT01272960 ·Status: COMPLETED ·Phase: NA
-
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
NCT00461253 ·Status: COMPLETED
-
Study of the Copper IUD or Oral Levonorgestrel and the Levonorgestrel IUD for Women Seeking Emergency Contraception
NCT01963962 ·Status: COMPLETED
-
Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial
NCT00653159 ·Status: COMPLETED ·Phase: PHASE4
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
NCT00360490 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
NCT05139121 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
NCT01309919 ·Status: COMPLETED ·Phase: NA
-
Pericoital Oral Contraception With Levonorgestrel
NCT00922233 ·Status: COMPLETED ·Phase: PHASE3
-
Pretreatment With Mifepristone Prior to Mirena Insertion
NCT01931657 ·Status: COMPLETED ·Phase: PHASE2